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nanorods for improving hyperthermia efficacy
Shan Zhao1, Nanjing Hao1, John X. J. Zhang1, P. Jack Hoopes1,2, Fridon Shubitidze1 and Zi Chen1,3*

Abstract
Background: Hyperthermia is one of the promising cancer treatment strategies enabled by local heating with the
use of tumor-targeting magnetic nanoparticles (MNP) under a non-invasive magnetic field. However, one of the
remaining challenges is how to achieve therapeutic levels of heat (without causing damages to regular tissues) in
tumors that cannot be effectively treated with anti-tumor drug delivery.
Results: In this work, we report a facile method to fabricate magnetic nanorods for hyperthermia by one-step wet
chemistry synthesis using 3-Aminopropyltrimethoxysilane (APTMS) as the shape-controlling agent and ferric and
ferrous ions as precursors. By adjusting the concentration of APTMS, hydrothermal reaction time, ratios of ferric to ferrous ions, magnetic nanorods with aspect ratios ranging from 4.4 to 7.6 have been produced. At the clinically recommended field strength of 300 Oe (or less) and the frequency of 184 kHz, the specific absorption rate (SAR) of these
nanorods is approximately 50 % higher than that of commercial Bionized NanoFerrite particles.
Conclusions: This increase in SAR, especially at low field strengths, is crucial for treating deep tumors, such as pancreatic and rectal cancers, by avoiding the generation of harmful eddy current heating in normal tissues.
Background
Hyperthermia is one of the conventional methods in
cancer therapeutics, whose efficacy, however, is limited
by the relatively low heating efficiency. Hyperthermia
can be induced in tumor tissue by embedding magnetic
nanoparticles and activating them with an alternating
magnetic field and cell death can occur when a sufficient cumulative effective heat dose is reached [1–4]. The
treatment can be targeted to the tumor area by accurate
placement of the nanoparticles and targeting the activating magnetic field [5, 6]. Compared with chemotherapy
and radiotherapy, targeted hyperthermia therapy has
the potential to have fewer systemic side effects and less
damage to the surrounding normal tissue [7–11]. In the
past, a limitation for magnetic hyperthermia is the difficulty of generating sufficient heat in the tumor area
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with a biologically safe AMF (alternating magnetic field).
Even with direct injection into the tumor, it is difficult to
deliver a sufficient thermal dose with reasonable injected
MNP volumes [2, 7, 9]. In each environment, the heating
achieved is determined by the amount of iron in the target area and the watts per gram (SAR/specific absorption
rate) of heat created by that iron when it is exposed to an
alternating magnetic field [12–14]. AMF field strengths
are limited by safety concerns over eddy current heating
and tissue uptake can limit iron concentrations in the tissue. Therefore, any increase in the SAR of the iron present in the target area would be advantageous. In order to
achieve an efficient heat treatment with minimal normal
tissue risk for cancer patients, it is imperative to develop
new magnetic nanomaterials with high heating efficiency
or SAR at the lowest particle dose [15–17]. Since, the
SAR value strongly depends on the intrinsic properties
including saturation magnetization (Ms) and geometric anisotropy of the nanoparticles [18], one effective
method to improve SAR is to increase the nanoparticle
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anisotropy and Ms by modifying their shape and/or size
[15, 19].
Anisotropic one-dimensional (1D) nanostructured
materials (nanotubes, nanorods and nanowires) are
favorable due to the restricted carrier motion in two
directions, high surface to volume ratio, and a proven
increase of selective attachment to specific organs [20].
1D iron oxide materials, such as nanorods, nanotubes,
nanowires and nanobelts, are found to have potential
applications in medical, electrical, magnetic and optical
nanodevices [21]. The most common iron oxide crystallites include hematite (α-Fe2O3), maghemite (γ-Fe2O3),
goethite (α-FeOOH), akageneite (β-FeOOH or ClFeOOH), and magnetite (Fe3O4).
Due to its unique superparamagnetic properties, magnetite (Fe3O4) offers excellent potentials in biomedicine.
These potentials include magnetic separation, therapeutic drug delivery, radio frequency methods for tumor
ablation via hyperthermia and contrast enhancement
agents for magnetic resonance imaging [22]. Previous
researchers [23–25] have confirmed the biocompatibility
of magnetite, which makes it a very promising candidate
for biomedical applications. A wide variety of magnetite
nanorods have been developed: Vayssieres et al. [26] have
developed an aqueous chemical growth of oriented threedimensional crystalline nanorod arrays of Fe(III) oxides;
Ramírez and co-workers [27] reported synthesis of a high
magnetite fraction in superparamagnetic nanospheres by
a three-step mini-emulsion polymerization; Ding et al.
[28] prepared magnetite nanorods in the presence of
PANI nanorods; Zhang et al. [29] reported new nanorods
using reverse co-precipitation technique with external
magnetic field. In the previous works, synthesis of spindle magnetic oxide needed multi-steps of processing.
Although Wan et al. [21] and Chen et al. [30] reported
two facile approaches to fabricate Fe3O4 nanorods with
the length ranging from 200 to 2000 nm, they were nonuniformly dispersed. The agglomeration of these particles
originates from the strong interaction among the particles, which will diminish their magnetic properties [28].
Si et al. [31] presented a solvothermal method to prepare
single crystal water-phased Fe3O4 nanorods with a tunable aspect ratio (length from 58 to 250 nm, width from 8
to 64 nm). Das [32] designed a crystalline Fe3O4 nanorod
with a tunable aspect ratio, which showed significantly
enhanced SAR values compared to their spherical and
cubic counterparts. They also found that increasing the
aspect ratio of the nanorods from 6 to 11 could improve
SAR by 1.5 times. Most recently, Salvador et al. designed
superparamagnetic magnetite nanoparticles of the
size between 5.4 and 7.2 nm using a W/O microemulsion system, which could be advantageous in effectively
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controlling the size, shape, and composition of the nanoparticles [33]. Konopacki et al. indicated that the rotating magnetic field can serve as a reinforcing factor on the
heating distribution of nanoparticles (GO, Fe3O4) and
hybrid material (GO/Fe3O4), and also showed the promise of using hybrid material as an effective hyperthermia
agent [34].
As one of the iron oxide crystals, akaganeite has the
less common bcc packing rather than the hcp packing
in goethite and hematite [35]. The octahedra with faceshared double chains of (FeO6)−6 would propagate along
fourfold symmetrical b-axis, which offers an open tunnel
lattice structure to accommodate anionic species [36].
The tunnels turn parallel to the b-axis and are delineated by (110) plane. Unlike goethite that is stabilized by
integrating with OH−, akaganeite is usually stabilized by
F− or Cl− [35]. Crystallographically, akaganeite exhibits
a hollandite-like structure with monoclinic symmetry
[35], and it tends to grow into crystalline 1-D irregularly
shaped, ellipsoidal nanostructure [37]. Therefore, akaganeite can serve as the intermediate phase for the nucleation of the oxide phase, thereby playing a role in defining
the final 1-D nanostructure [38].
In this work, we developed a direct 3-aminopropyltrimethoxy-silane (APTMS)-assisted hydrothermal method
to fabricate magnetic nanorods with intermediate aspect
ratio and enhanced magnetic heating properties. The
effect of the reaction conditions, including the quantities
of APTMS, hydrothermal reaction time, ratios of Fe(II)
to Fe(III) ions, on the morphology of magnetic nanorods
and the hyperthermia response of nanostructures was
identified. The probable nanorod growth mechanism
from intermediate akaganeite phase and the heating
mechanism were further discussed in this paper.

Results
Characterizations of magnetic nanorod

Representative TEM micrograph of nanorods is presented in Fig. 1a. Using TEM imaging, we are able to
show the structure and size distribution (range 50–70
nm in length and 8–10 nm in width) of the nanorods. The
average aspect ratio is 5.75 for these nanorods (Fig. 1b).
X-ray diffraction (XRD) is used to determine the purity
and phase structure of nanoparticles. The XRD pattern
(Fig. 2a) confirms the coexistence of the akageneite-M
(space group: tl4/m), akageneite (Ml2/m), magnetite
(cFd-3m) and hematite (hR-3c). The diffraction peaks
indexed to the (110), (400), (440), (533), (444) planes
imply the spinel cubic structure (space group: Fd3m),
confirming the crystallization of the standard magnetite
(JCPDS:19–0629) [39]. For the representative nanorod
sample (Fig. 2b), the structural refinement indicates 21.9
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wt% of magnetite and 1.9 % of hematite. The observation
of hematite could also due to the drying process in air
which transformed magnetite to hematite.
The magnetization curve of the representative nanorod
sample shows superparamagnetic behavior with saturation magnetization of 28 emu/g (Fig. 3). The magnetization value of nanorod is much larger than the previous
reported pure hematite alone [40, 41], which could due to
the ferromagnetic nature of magnetite, of which the magnetization in pure form can reach up to 100 emu/g [42].
Inductive heating properties of nanorod

We demonstrate in Fig. 4 that by changing the strength
of the applied AMF field, and the nanorod concentrations, the final temperature reached can be controlled.
At the tested AMF field strengths 261 Oe through 641
Oe, nanorods have been proven to produce more heat
and with increasing the field strengths. In Fig. 4, we have
plotted the heating curves of nanorods in water for two
different concentrations, 5 and 10 mg/mL, respectively.
The nanorod solution with a concentration of 10 mg/
mL produced a temperature increase of 11.5 °C in 60 s
at 641 Oe, while that with a concentration of 5 mg/mL
produced a temperature increase of 9.5 °C over the same
time period. Since no significant hysteresis was observed
(Fig. 3), the field-driven viscous frictional loss could be a
major source of the generated. At a low field strength of
132–385 Oe there is no obvious distinction in the heating efficiency between these two samples, whereas at a
higher field strength of 522 or 641 Oe, the heating efficiency shows an observable variation depending on the
iron concentration. This discrepancy implies that the loss
of heat due to friction or resistance of viscosity (concentrations) in a low oscillating magnetic field is less prominent than that in a high field.
As shown in Fig. 5, under an AMF of 261, 395, 522
Oe at 184 kHz, nanorods of 5 mg/ml displayed the
SAR (specific aspect ratio) values of 69, 154, 246 W/g
respectively, which is approximately 50 % higher than
that of commercial Bionized NanoFerrite (BNF) particles [43]. In this paper, we used the commercial Bionized NanoFerrite particles as a benchmark to our
nanorod because we wanted to make sure that both
group of those data are collected in the same instrument using the same setup, same frequencies and field
strength. Since all SAR depends not only the material but also the testing parameters, such as frequencies and field strength, and the higher frequencies and
field strength one uses, the higher SAR one can get
for the same sample. Since the AMF-based hyperthermia (mNPH) system we used to test the SAR was custom built, the heating measurements were performed
using a 14-turn, air core, copper solenoid coil (internal
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diameter 32 mm, length 12 cm), which was powered by
a 10 kW TIG 10/300 generator (Hüttinger Elektronik
GmbH, Freiburg, Germany) and cooled by running
water kept at 20 oC by a closed circuit chiller [43]. It is
not easy to compare the magnetic properties between
our nanorods and other magnetic nanomaterials since
they were tested under different frequencies and field
strength than ours. For example, most data of SAR
shown in Table 1 from Hervault et al. [3] were tested
at frequencies over 400 kHZ, while in our case we use
184 kHz, which is more clinically relevant; the only
example listed in Table 1 [3] using 100 kHz and 377 Oe
had an SAR of 29 W/g, which is far less than our value
of 154 W/g at frequency of 184 kHz and field strength
of 395 Oe. This increase in SAR especially in a low field
strength (300 Oe or less, clinical recommended [44])
is crucial for treating deep tumors, such as pancreatic
and rectal cancers. The AMF produced by a coil can
penetrate inside tissue and activate heating of MNPs
in tissues, meanwhile due to the AMF, the unwanted
eddy currents in the normal tissues also occurs [45,
46]. Defined by Faraday’s law, the absorbed power density in tissue due to eddy currents is σ(πµ0Hfr)2 = σE2,
where f is the frequency, σ is the tissue conductivity, µ0
is the permeability of free space, r is the radial position
within the solenoid in which the tissue exists, E is the
electric field and H is the magnetic field [45]. Therefore,
lowering field strengths could be an alternative to produce lower unwanted eddy current heating in surficial
tissues.
Influence of the APTMS concentrations

The TEM images in Fig. 6a demonstrate nanorods synthesized at different concentrations of APTMS, while
keeping the ratio of F
e3+/Fe2+ (2:1) and hydrothermal
time (12 h) constant. The grown nanorod crystals are
seen to increase in aspect ratio with increasing concentrations of APTMS (Fig. 3), from 4.4 to 5.1 to 5.5 and
7.6, respectively. At low concentration of APTMS (0
mM ≤ [APTMS] ≤ 19 mM), an increased occurrence
of crystallographic twinning of nanocrystals is seen as
the four-pointed stars. The crystallographic twinning of
nanocrystals grown from solutions could result from the
(332) twin system with an angle of 62 ° [47]. The existence of small amount of Si (from APTMS) in β-FeOOH
increases the twinning [47].
TEM images further confirmed the formation of
nanorods with a narrow size distribution. The average
dimension of the nanorods is 100 nm×20 nm, 65 nm×11
nm, and 80 nm×10 nm for different concentrations of
APTMS (19, 56, 223 mM), respectively. Higher [APTMS]
is shown to aid the more regular arrangement arrays of
monodisperse nanorods along longitudinal directions.
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Fig. 1 TEM image of magnetic nanorod with Fe3+/Fe2+=2:1 (hydrothermal for 3 h) and derived aspect ratio probability density (b)

This may be linked to base nature of APTMS in water,
which modulates the assembly pathway of the polymorphs nanorods in solution.
The IR transmittance spectrum provides surface chemistry of nanorod (Fig. 7). The bands at 3200–3550 cm− 1
due to the ɣ(O-H) vibration of H2O can be observed
and this broadening is related to the presence of N-H
stretching at 3378 cm− 1 [48]. The bands at 660 and 923,
1050–1250 cm− 1 are the characteristic Fe-O and Si-O-Fe
vibrations [49, 50]. Additionally, the C
 H3 at 2939 cm− 1
−1
and NH2 bending at 1599 cm substantiate the APTMS
functionalization on iron oxide [48]. Several sharp peaks
are observed in the range 1460 − 1113 cm− 1, due to the
methylene (-CH2-) and methyl (-CH3) group bending and
C-O stretching [51].
Influence of the Fe3+/Fe2+ molar ratio

Co-precipitation from a solution of ferrous/ferric mixed
salt has great promise in producing magnetic particles
due to its ease and economy [52]. In our experiment, the
magnetic nanorods with the particle size ranging from 40
to 300 nm were successfully prepared by controlling the
reaction condition (Fig. 8).
The XRD patterns and TEM images of products
obtained at different ionic ratios were shown in Figs. 2a
and 8, respectively. In the molar ratio of ferric ion to ferrous ion at 1:12, some irregular dark aggregates were

surrounded by the small needle-like nanoparticles particles (Fig. 8a). Increasing the ratio from 1:12 to 1:6, the
irregular aggregates became more rhombohedra-like.
At ratios over 1:2, more regular nanorods were found
and growing; while dark aggregates were gradually
diminished.
The pathways for oxide nucleation after akageneite formation have been found to rely on reagent concentration
and pH: at low ferric concentration, the transformation
from akaganeite to Fe-O was reported to be purely a dissolution/reprecipitation pathway, while at higher concentration the akaganeite rods assemble into rafts, which
serves as a template for the Fe-O nucleation [38]. Increasing molar ratio of ferric ion to ferrous ion from 1:12 to
12:1, also increases the number of nanoreactors and
rapid formation of the ferric hydroxide, which in turn,
increases the concentration of the colloidal nanoparticles. At high concentration of the colloidal nanoparticles
the probability of collisions increases, leading to aggregation and formation of nanoparticles with bigger size [53].
From the calculated aspect ratios, a narrower distribution of nanorod was found at molar ratio of 2:1. The role
of akaganeite-akaganeite interfaces as templates for Fe-O
nucleation, together with the ability of akaganeite colloids
to assembly into structures with long-range orientational
order in solution, is important in determining the nanosized magnetic crystals with variety of shapes [37, 47, 54].
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Influence of the hydrothermal time
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Fig. 3 Magnetization versus magnetic field strength for magnetic
nanorod with Fe3+/Fe2+=2:1 (hydrothermal for 9 h)

In order to probe the reaction conditions on the heating
efficiency of the nanorods, we analyzed and compared
the heating curves and SAR values of samples with varied APTMS concentration, ionic ratios, and hydrothermal time. Figure 10 (a1,b1,c1) represents heating curves
for the nanorods at a concentration of 5 mg/mL in water.
SAR values increase with increasing concentrations of
APTMS from 118 W/g to 149 W/g, and then decreases
slightly to 136 W/g. As we noticed earlier in Fig. 6b,
aspect ratios of the nanorods increased with increasing
concentrations of APTMS from 4.4 to 7.6. These results
clearly suggest that the aspect ratio of the nanorods plays
an important role in their heating efficiency. Another factor that must be considered is the nanorod alignment
[32]. A decrease of the heating rate when the nanorods
are pointing randomly in the water solution (Fig. 6a) suggests that their heating efficiency is improved when they
are more aligned in the direction (Fig. 6a).
As demonstrated in Fig. 10 (b1, b2), increasing the
molar ratio of ferric ion to ferrous ion from 1:12 to 12:1
results in an increased heating rate. SAR is calculated
to increase from 87 W/g to 246 W/g, followed by slight
decrease to 189 W/g. The increase of SAR from 87 W/g
to 246 W/g at molar ratio of 1:12 to 2:1 indicates that
positive effect of particle size and the morphology of
nanorod on heating efficiency. While from molar ratio
of 2:1 to 12:1, a wider size distribution of nanorod was
observed from Fig. 8b, which could be accounted for the
decrease of SAR from 246 W/g to 189 W/g.
Figure 10 (c1, c2) represents the heating properties
for the nanorods at changing hydrothermal times. From
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Fig. 4 Temperature versus time for nanorod (with Fe3+/Fe2+=2:1, hydrothermal for 9 h) at different field strengths at a frequency of 184 kHz

our further studies, a hydrophilic coating may be applied
in order to avoid aggregation between nanorods.

Discussion
Understanding the heating mechanism of magnetic
nanorods

Fig. 5 SAR for 5 mg/ml magnetic nanorod (with Fe3+/Fe2+=2:1,
hydrothermal for 9 h) and commercial BNF particle at a frequency of
184 kHz. The SAR for BNF is given for comparison

0.5 h to 6 h hydrothermal reaction, the SAR is increased
from 94 W/g to 178 W/g. SAR drops slightly to 147 W/g
at 12 h. This confirms the positive role of particle size,
the morphology of nanorod, and narrow distribution of
nanorod size (Fig. 9a,b) on heating efficiency.
It should be noted that the TEM results showed that
magnetic rods were present in the aggregated form. This
aggregation may reduce the heating efficiency [32, 56],
however the aggregation is inevitable in our scenario
since the nature of the nanorod is magnetic. Similar
aggregations were also found in other paper [43, 57]. In

The lack of hysteresis heating in Fig. 3 indicates the generated power generally results from the particle rotations
and frictions: under external AMF, the magnetic particles undergo translational (Ft = m ∇ ∇H) and rotational
forces (Fr = m × H), which relies on the gradient of the
AMF and the applied field respectively [43]. Due to these
exerted forces, the particles have the tendency to rotate
and motion and experience viscous friction in the colloid
solution. Under a fast AMF, the induced forces push particles to rotate and move more rapidly. In this way, the
applied AMF is changed into heat via frictional loss from
particles and the surrounding medium [58]. In the liquid
medium, the magnetic forces on the particles overcomes
the 12πηVf viscous frictional force and produces the specific loss power per unit mass of the particle as:

SAR =


1
2π f × Ms × H × m
ρ


β1 0 0
m =  0 β2 0  • H
0 0 β3

(1)

(2)

where V is volume of the particles, η is a viscosity of the
surrounding, f is the frequency of the field, ρ is the MNP
density, Ms is the saturation magnetization, H is applied
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Fig. 6 Representative TEM images a and aspect ratio probability densities b for nanorods with changing of APTMS from 0 to 1.2 g ( Fe3+/Fe2+=2:1,
hydrothermal for 12 h)
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Fig. 7 FTIR spectrum of nanorods

AMF on the MNP, m is the induced magnetic moment,
and β(1,2,3)are polarizabilities along the MNP principal
axis, and it depends on the geometry on MNP [43]. For

example, for a spherical MNP β1 = β2 = β3, and for a prolate spheroidal MNP β1 = β2 < β3 .
This expression (Eq. 2) shows that SAR resulting from
rotational friction is proportional to the square of the
local magnetic field since m is proportional to H, which
coincides with the measured SAR field dependence (
Figs. 4 and 5). In addition, at low particle concentrations,
the magnetic forces acting on the particles needs to overcome a smaller viscous frictional force (12πηVf ) than
that at a higher concentration, therefore a low oscillating
magnetic field is required to rotate/move the particles,
but at a high concentration, particles experience high viscous resistance from the surrounding medium, so that a
larger magnetic field will be needed to rotate clusters.
The previously reported Néel relaxation time (10− 9s)
and the frequency peaks for particles of size 2–5 nm
and 27 nm are at frequencies of 1.37 ~ 1.58 × 108 Hz or
8.5 × 10− 3 Hz, respectively. The frequency used in the
MNP hyperthermia in this study (~ 187 kHz), however, is
not within those ranges. Therefore, Néel relaxation [31]
is not considered as the main contributing factor to the
power losses here.
Eq. (2) and the measured data (Fig. 10) show that
the field-driven viscous frictional loss for the nanorod
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Fig. 8 TEM images a and aspect ratio probability densities b for nanorods with changing F e3+/ Fe2+ from 1:12 to 12:1 (APTMS is 0.05 g,
hydrothermal for 3 h)

Page 8 of 13

Zhao et al. J Nanobiotechnol

(2021) 19:63

Page 9 of 13

Fig. 9 TEM images a and aspect ratio probability densities b for nanorods with changing hydrothermal time from 0 to 12 h (APTMS is 0.05 g, F e3+/
F e2+= 2:1)
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Fig. 10 Heating curves (a1,b1,c1) and SAR plots (a2, b2, c2) for nanorod with varied APTMS concentration (a), ionic ratios (b), and hydrothermal
time (This increase in SAR, especially at low field strengths, is crucial for treating deep tumors, such as pancreatic and rectal cancers, by avoiding the
generation of harmful eddy current heating in normal tissues.) at fixed field strength of 395 Oe and a frequency of 184 kHz
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depends on the synthetic conditions. This frictional loss
changes with the variation in the nanorod size, morphology and the distribution of its aspect ratios. This variation results in a change in the polarizability β along the
principal axis, and hence an altered torque is generated
that rotates the particles in the axis parallel to the applied
AMF. Heating results from Fig. 10 combined with TEM
results in Figs. 6 and 8, and 9 indicate the critical role
of the hydrothermal time, ionic ratios and APTMS concentration on hyperthermia efficacy. As-made rod-like
nanoparticles with narrower particle distributions and
with aspect ratios in the range of 4.5–5.4 will result in
enhanced heating efficiency for hyperthermia therapy.

Conclusions
In this study, we developed a facile method to fabricate
magnetic nanorods for hyperthermia by one-step wet
chemistry synthesis using APTMS (3-Aminopropyltrimethoxysilane) and ferric and ferrous ions as precursors.
The existence of APTMS plays a key role in shape-controlling of nanoparticles. By adjusting the quantities
of APTMS, hydrothermal reaction time, ratios of ferric to ferrous ions, nanorods with aspect ratios ranging
from 4.4 to 7.6 have been produced. The nanorods prepared from 56 mM of APTMS, a molar ratio of ferric
ion to ferrous ion of 2:1 under the hydrothermal reaction for 9 h displays the SAR values of 69, 154, 246 W/g
at field strength of 261, 395, 522 Oe and radiofrequency
of 184 kHz respectively. As-made rod-like nanoparticles
with narrower particle distributions, and with aspect
ratios in the range of 4.5–5.4 demonstrates higher heating efficiency in hyperthermia therapy. At the clinically
recommended field strength of 300 Oe (or less), the SAR
of our nanorod is approximately 50 % higher than that of
commercial Bionized NanoFerrite particles. This increase
in SAR especially in low field strength (< 300 Oe) is crucial for treating deep tumors, such as pancreatic and
rectal cancers in order to avoid generating harmful eddy
current heating in healthy tissues.
Materials and methods
Chemicals

APTMS, ferric chloride (FeCl3), and ferrous chloride
tetrahydrate (FeCl2∙4H2O) were purchased from VWR,
Inc. All materials were used as received without any
additional purification. Deionized water was used in all
experiments.
Preparation

As a typical procedure, 30ml of 56 mM APTMS was vigorously stirred at room temperature for 30 min (pH = 11).
Then, 1.3 ml 1 M Fe(II) and 2.6 ml 1 M Fe(III) were added
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dropwise to precursors. After stirring at room temperature for 1 h, the dark brown mixture was transferred to
closed polypropylene bottles and heated for hydrothermal at 100 °C for 6 h under static conditions. The solids
were collected by filtration and dried in air at 60 °C. The
parameters that are essential for the formation of magnetic nanorods were studied by varying the APTMS content, hydrothermal time, and molar ratios of F
 e3+/Fe2+.
Characterization

Transmission electron microscopy was performed using
a Tecnai F20ST FEG TEM. Samples were first dispersed
in ethanol. A drop of the sample suspension was placed
on a copper grid and then dried in air. The size and
aspect ratio distributions of the TEM images were analyzed using the algorithm “Measure_ROI.class” from
Image J [59]. Probability density-aspect ratio curve was
calculated and fitted with Probability Density Function
(PDF) illustrated from Originlab (https://www.originlab.
com/doc/Tutorials/PeakFit-on-FreqCountResult).
The crystal phase of the nanorod was determined
using wide-angle X-ray diffraction (Philips APD 3720)
with Cu-Kα radiation (λ = 1.541Å). An accelerating voltage of 50 kV and an emission current of 100 mA were
used. Scans were recorded for 2θ values between 20
and 70 ° with a scanning speed of 2.4 °/min. The known
compounds underwent rietveld refinement to quantify
the weight % of each phase using MDI Jade 6.5. Fourier
transform infrared (FT-IR) spectra in the range 4000 to
500 cm− 1 were recorded on a Thermo Scientific Nicolet
6700 IR spectrophotometer with a spectral resolution of
4 cm− 1. The quasistatic magnetic properties of the nanoparticles were determined (saturation magnetization, Ms;
remnant magnetization, Mr; and coercivity, Hc) using a
Lakeshore model 7300 Vibrating Sample Magnetometer
(VSM).
Heating measurements were performed using a
14-turn, air core, copper solenoid coil (internal diameter
32 mm, length 12 cm), which was powered by a 10 kW
TIG 10/300 generator (Hüttinger Elektronik GmbH,
Freiburg, Germany) and cooled by running water kept at
20 °C by a closed circuit chiller. A 0.7mm diameter fiber
optic probe (FISO Inc, Quebec, Canada), accurate to 0.1
°C, was used for the temperature measurements. A fiber
optic temperature probe was positioned in the sample,
close to the center of the coil, to measure temperature in
the sample. Experiments were performed over a range of
at least 132-641Oe at frequency of 184 kHz. Two nanorod
samples with a concentration of 5 mg/ml and 10 mg/ml
were tested. The sample was placed at the center of the
coil, where the field strength was most homogeneous.
The temperature was recorded electronically at one second intervals throughout the experimental period and
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monitored using a real-time temperature monitoring
system. The SAR was calculated based on the initial temperature rise recorded [3]:

SAR =

Cp × ∆T
∆t × mN P

(3)

where C is the specific heat capacity of the media (in our
case, it was water C
 p=4180 J/kg K; the amount of Fe was
commonly neglected here), T is the temperature (K),
mNP is a dimensionless parameter that stands for the
mass of nanoparticles per unit mass of liquid, and t is
the time (s). SAR data for BNF particles from Shubitidze
et al. [43] are shown in Fig. 5 for comparison. The solid
content for the BNF is 25 mg/ml, and the iron concentration is 13.7 mg/ml.
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